Literature DB >> 16643573

Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey.

Christian Lucas1, Gilles Géraud, Dominique Valade, Marie-Hélène Chautard, Michel Lantéri-Minet.   

Abstract

OBJECTIVE: To evaluate the proportion of migraineurs who are self-aware of their disease in France, to determine the factors (disability, quality of life, psychiatric comorbidities, and medical consultation) that may promote self-awareness of migraine, and to assess the influence of these factors on migraine attacks.
BACKGROUND: New recommendations for migraine diagnosis and medical management were released in 2003 by the French medicoeconomic evaluation service (ANAES). In addition, the revised classification of headache disorders recently issued by the International Headache Society includes probable migraine as a form of migraine. However, strict and probable migraine now appear to be part of the same spectrum of disease.
METHODS: Subjects with migraine (strict or probable) according to the revised classification were identified by a postal questionnaire from a large representative sample of the French adult population. Migraine-related disability was assessed using the MIDAS questionnaire, anxiety and depression by the Hospital Anxiety and Depression scale (HADS), and health-related quality of life (HRQoL) by the 8 concepts of the Short-Form 12 (SF-12) questionnaire. Migraine management was assessed according to the use of recommended or nonrecommended treatments, and treatment efficacy according to the set of 4 questions designed by the ANAES.
RESULTS: Of the 10,532 subjects interviewed, 1,179 subjects (21.3%) were identified as migraineurs. Sixty percent of all migraine subjects were not self-aware that they had migraine. Medical consultation, duration of migraine history, severe intensity of attacks, impact on daily living, and female gender promoted self-awareness of migraine. On the other hand, HRQoL and anxiety and depression scores were not different between subjects self-aware or not self-aware of migraine. Only 20% of all migraine subjects were medically followed-up. Quality of the first medical consultation appears determinant for continued consulting. Subjects self-aware of migraine more frequently used recommended acute treatments of migraine, which proved more effective than nonrecommended treatments as assessed according to the ANAES set of questions.
CONCLUSIONS: Migraine medical diagnosis and follow-up remain low in France. Careful medical consultation is a prime factor for migraine subject self-awareness of migraine, continued consultation, and use of recommended medications for the treatment of migraine attacks.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16643573     DOI: 10.1111/j.1526-4610.2006.00430.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  36 in total

Review 1.  Ibuprofen with or without an antiemetic for acute migraine headaches in adults.

Authors:  Roy Rabbie; Sheena Derry; R Andrew Moore; Henry J McQuay
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

2.  Sumatriptan plus naproxen for acute migraine headaches in adults.

Authors:  Simon Law; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2010

3.  Zolmitriptan for acute migraine headaches in adults.

Authors:  Sheena Derry; R Andrew Moore; Henry J McQuay
Journal:  Cochrane Database Syst Rev       Date:  2010

4.  Eletriptan for acute migraine headaches in adults.

Authors:  Sheena Derry; R Andrew Moore; Henry J McQuay
Journal:  Cochrane Database Syst Rev       Date:  2010

5.  Rizatriptan for acute migraine headaches in adults.

Authors:  Rebecca Ling; Sheena Derry; R Andrew Moore; Henry J McQuay; Philip J Wiffen
Journal:  Cochrane Database Syst Rev       Date:  2010

Review 6.  Aspirin with or without an antiemetic for acute migraine headaches in adults.

Authors:  Varo Kirthi; Sheena Derry; R Andrew Moore; Henry J McQuay
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

7.  Population-based study of migraine in Spanish adults: relation to socio-demographic factors, lifestyle and co-morbidity with other conditions.

Authors:  César Fernández-de-Las-Peñas; Valentín Hernández-Barrera; Pilar Carrasco-Garrido; Cristina Alonso-Blanco; Domingo Palacios-Ceña; Silvia Jiménez-Sánchez; Rodrigo Jiménez-García
Journal:  J Headache Pain       Date:  2009-12-10       Impact factor: 7.277

Review 8.  Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults.

Authors:  Simon Law; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2016-04-20

9.  Impact of a public sensitization campaign on migraine management in France.

Authors:  Anne Donnet; Michel Lantéri-Minet; Gilles Géraud; Evelyne Guegan-Massardier; Geneviève Demarquay; Pierric Giraud; Christian Lucas; Dominique Valade
Journal:  J Headache Pain       Date:  2009-05-30       Impact factor: 7.277

10.  Diagnosing migraine in research and clinical settings: the validation of the Structured Migraine Interview (SMI).

Authors:  Zainab Samaan; E Anne Macgregor; Dowson Andrew; Peter McGuffin; Anne Farmer
Journal:  BMC Neurol       Date:  2010-01-14       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.